Clinuvel Pharmaceuticals Ltd (CUV), CEO & MD Dr Philippe Wolgen
Clinuvel Pharmaceuticals Ltd (CUV), CEO & MD Dr Philippe Wolgen speaks with Tom Piotrowski about the company’s focus on treating a range of severe skin disorders, recent FDA announcement & market opportunity for SCENESSE in the US.
11 Oct 2019